Objectives
The purpose of this prospective study was to assess the normal physiologic ranges of the renal corticomedullary 23Na-concentration ([23Na]) gradient at 3.0T in healthy volunteers. The corticomedullary [23Na] gradient was correlated with other functional MR imaging parameters—blood oxygenation level dependent (BOLD) and diffusion-weighted imaging (DWI)—and to individual and physiologic parameters—age, gender, estimated glomerular filtration rate (eGFR), body mass index (BMI), and blood serum sodium concentration ([23Na]serum).Methods and materials
50 healthy volunteers (30 m, 20 w; mean age: 29.2 years) were included in this IRB-approved study, without a specific a priori preparation in regard to water or food intake. For 23Na-imaging a 3D density adapted, radial gradient echo (GRE)-sequence (spatial resolution = 5 × 5 × 5 mm3) was used in combination with a dedicated 23Na-coil and 23Na-reference phantoms. [23Na] values of the corticomedullary [23Na] gradient were measured by placement of a linear region of interest (20 × 1 mm2) from the renal cortex in the direction of the renal medulla. By using external standard reference phantoms, [23Na] was calculated in mmol/L of wet tissue volume (mmol/l WTV). Axial diffusion-weighted images (spatial resolution = 1.7 × 1.7 × 5.0 mm3) and 2D GRE BOLD images (spatial resolution = 1.2 × 1.2 × 4.0 mm3) were acquired. Mean values ± standard deviations for [23Na], apparent diffusion coefficient (ADC) values, and R2* values were computed for each volunteer. The corticomedullary 23Na-concentration gradient (in mmol/l/mm) was calculated along the area of linear concentration increase from the cortex in the direction of the medulla. Correlations between the [23Na] and DWI, BOLD, and the physiologic parameters were assessed with Pearson correlation coefficients.Results
The mean corticomedullary [23Na] for all healthy volunteers increased from the renal cortex (58 ± 17 mmol/l WTV) in the direction of the medulla (99 ± 18 mmol/l WTV). The inter-individual differences ranged from respective cortical and medullary values of 27 and 63 mmol/L WTV to 126 and 187 mmol/L WTV. No statistically significant differences in renal [23Na] were found based on differences in individual or physiologic parameters (age, gender, [23Na]serum, BMI, GFR). No ADC or R2* gradients were identified, and [23Na] did not correlate with these parameters.Conclusion
Renal corticomedullary [23Na] values increase from the cortex in the direction of the medullary pyramid, demonstrating wide inter-individual ranges and no significant correlations with age, gender, [23Na]serum, BMI, GFR, ADC, or R2* values. For future clinical evaluations, an approach relying on renal stimulation (e.g. pharmacologically induced diuresis) may be applicable to account for wide inter-individual ranges of normal [23Na]. 相似文献Amide proton transfer (APT) weighted chemical exchange saturation transfer (CEST) imaging is increasingly used to investigate high-grade, enhancing brain tumours. Non-enhancing glioma is currently less studied, but shows heterogeneous pathophysiology with subtypes having equally poor prognosis as enhancing glioma. Here, we investigate the use of CEST MRI to best differentiate non-enhancing glioma from healthy tissue and image tumour heterogeneity.
Materials & MethodsA 3D pulsed CEST sequence was applied at 3 Tesla with whole tumour coverage and 31 off-resonance frequencies (+6 to -6 ppm) in 18 patients with non-enhancing glioma. Magnetisation transfer ratio asymmetry (MTRasym) and Lorentzian difference (LD) maps at 3.5 ppm were compared for differentiation of tumour versus normal appearing white matter. Heterogeneity was mapped by calculating volume percentages of the tumour showing hyperintense APT-weighted signal.
ResultsLDamide gave greater effect sizes than MTRasym to differentiate non-enhancing glioma from normal appearing white matter. On average, 17.9 % ± 13.3 % (min–max: 2.4 %–54.5 %) of the tumour volume showed hyperintense LDamide in non-enhancing glioma.
ConclusionThis works illustrates the need for whole tumour coverage to investigate heterogeneity in increased APT-weighted CEST signal in non-enhancing glioma. Future work should investigate whether targeting hyperintense LDamide regions for biopsies improves diagnosis of non-enhancing glioma.
相似文献To improve the precision of a free-breathing 3D saturation-recovery-based myocardial T1 mapping sequence using a post-processing 3D denoising technique.
MethodsA T1 phantom and 15 healthy subjects were scanned on a 1.5 T MRI scanner using 3D saturation-recovery single-shot acquisition (SASHA) for myocardial T1 mapping. A 3D denoising technique was applied to the native T1-weighted images before pixel-wise T1 fitting. The denoising technique imposes edge-preserving regularity and exploits the co-occurrence of 3D spatial gradients in the native T1-weighted images by incorporating a multi-contrast Beltrami regularization. Additionally, 2D modified Look-Locker inversion recovery (MOLLI) acquisitions were performed for comparison purposes. Accuracy and precision were measured in the myocardial septum of 2D MOLLI and 3D SASHA T1 maps and then compared. Furthermore, the accuracy and precision of the proposed approach were evaluated in a standardized phantom in comparison to an inversion-recovery spin-echo sequence (IRSE).
ResultsFor the phantom study, Bland–Altman plots showed good agreement in terms of accuracy between IRSE and 3D SASHA, both on non-denoised and denoised T1 maps (mean difference −1.4 ± 18.9 ms and −4.4 ± 21.2 ms, respectively), while 2D MOLLI generally underestimated the T1 values (69.4 ± 48.4 ms). For the in vivo study, there was a statistical difference between the precision measured on 2D MOLLI and on non-denoised 3D SASHA T1 maps (P = 0.005), while there was no statistical difference after denoising (P = 0.95).
ConclusionThe precision of 3D SASHA myocardial T1 mapping was substantially improved using a 3D Beltrami regularization based denoising technique and was similar to that of 2D MOLLI T1 mapping, while preserving the higher accuracy and whole-heart coverage of 3D SASHA.
相似文献Object
To examine the whole brain white matter morphology in antipsychotic-naive patients with first-episode schizophrenia (FES) and its correlations with symptom severity.Materials and methods
High-resolution T1-weighted images of 64 drug-naive FES patients and 64 matched healthy controls were acquired using a 3 T MR imaging system. Then, optimized voxel-based morphometry was performed to compare the group differences. Finally, correlation analyses were conducted between the white matter volume (WMV) changes and clinical symptoms.Results
The FES showed significantly decreased WMV in the bilateral posterior limb of the internal capsule (PLIC) and right subgyral frontal white matter. The volume of the bilateral PLIC was negatively correlated with the Positive and Negative Syndrome Scale positive scores. Positive correlations were observed between all of the changed WMV measures and the Global Assessment of Functioning scores.Conclusion
The current findings provide further evidence to support internal capsule and subgyral frontal white matter deficits at the early stage of schizophrenia that are potentially related to the core pathophysiology of the disease. Furthermore, these anatomical alterations were related to the clinical symptoms but not the untreated illness duration, suggesting that these deficits are related to aberrations in the neurodevelopmental process and may be relatively stable during the early course of schizophrenia. 相似文献Clinical relevance of dynamic glucose enhanced (DGE) chemical exchange saturation transfer (CEST) imaging has mostly been demonstrated at ultra-high field (UHF) due to low effect size. Results of a cohort study at clinical field strength are shown herein.
Materials and methodsMotion and field inhomogeneity corrected T1ρ‐based DGE (DGE⍴) images were acquired before, during and after a d-glucose injection with 6.3 s temporal resolution to detect accumulation in the brain. Six glioma patients with clear blood–brain barrier (BBB) leakage, two glioma patients with suspected BBB leakage, and three glioma patients without BBB leakage were scanned at 3 T.
ResultsIn high-grade gliomas with BBB leakage, d-glucose uptake could be detected in the gadolinium (Gd) enhancing region as well as in the tumor necrosis with a maximum increase of ∆DGE⍴ around 0.25%, whereas unaffected white matter did not show any significant DGE⍴ increase. Glioma patients without Gd enhancement showed no detectable DGE⍴ effect within the tumor.
ConclusionFirst application of DGE⍴ in a patient cohort shows an association between BBB leakage and DGE signal irrespective of the tumor grade. This indicates that glucoCEST corresponds more to the disruptions of BBB with Gd uptake than to the molecular tumor profile or tumor grading.
相似文献